Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,883 | 11,870 | 14,962 | -3,759 | -1,961 |
| Depreciation Amortization | 1,069 | 563 | 17 | 12 | 6 |
| Income taxes - deferred | 16 | -833 | N/A | N/A | N/A |
| Accounts receivable | 105 | -247 | 102 | 57 | -55 |
| Accounts payable and accrued liabilities | 1,867 | 96 | -698 | -683 | -414 |
| Other Working Capital | 1,907 | -199 | -723 | -857 | -627 |
| Other Operating Activity | -1,361 | 1,329 | 1,468 | 1,235 | 815 |
| Operating Cash Flow | $-280 | $12,579 | $15,128 | $-3,996 | $-2,237 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -23 | -8 | -2 | -2 |
| Net Acquisitions | 0 | -18,889 | N/A | N/A | N/A |
| Investing Cash Flow | $-19 | $-18,912 | $-8 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,374 | -2,374 | -1,767 | -875 |
| Common Stock Issued | 363 | 1,740 | 6,379 | 6,379 | 1,187 |
| Other Financing Activity | 0 | 4,371 | -279 | -279 | -191 |
| Financing Cash Flow | $363 | $3,737 | $3,726 | $4,332 | $121 |
| Beginning Cash Position | 2,606 | 5,202 | 5,202 | 5,202 | 5,202 |
| End Cash Position | 2,669 | 2,606 | 24,047 | 5,537 | 3,085 |
| Net Cash Flow | $64 | $-2,596 | $18,846 | $335 | $-2,117 |
| Free Cash Flow | |||||
| Operating Cash Flow | -280 | 12,579 | 15,128 | -3,996 | -2,237 |
| Capital Expenditure | -19 | -23 | -8 | -2 | -2 |
| Free Cash Flow | -300 | 12,556 | 15,120 | -3,997 | -2,238 |